Claudia Damiani, CTO: awarded a first-class honours Master’s Degree in 2005 at University of Camerino.
During her PhD he worked at the "Centre National de Recherché et de Formation sur le Paludisme" in Ouagadougou in Burkina Faso.
She also worked at Duquesne University (Pittsburgh, USA) in Prof. David Lampe's laboratories, on genetic manipulation of bacteria, using a recombinant plasmid.
Dr. Damiani won a scholarship in 2011, as part of the FIRB-IDEAS project. She won a FIRB financing for young researchers in 2013 and is working at the University of Camerino as a contract researcher, on the project "Yeasts and killer peptides, as experimental models for the control and treatment of diseases transmitted by arthropod vectors". Dr. Damiani is a mother of three. She is the author of 21 publications in trade magazines.
Dr. Aurelio Serrao, CEO: Dr. Aurelio Serrao holds a first-class honours Master's Degree in Biomedical Molecular Science obtained in 2008 at the University of Perugia subsequently, won two research scholarships.
He collaborated with Dr. Catteruccia in a research project entitled "Anopheles reproductive biology".
He received his PhD in "Transmissible agents that cause the main diseases that cause poverty" by discussing a thesis on the role of the mosquito neurotransmitters and their implication in reproductive behaviour. During the PhD, he worked in Boston at the Harvard School of Public Health and at Imperial College in London in order to complete his project.
Matteo Valzano, COO: Dr. Matteo Valzano was awarded first-class honours Master’s Degree in Biomolecular and Biofunctional Sciences in 2009 at University of Camerino.
During his Ph.D. he reached the "ATP" finals at the 9th edition of the European level context "Innovact Campus Award" with the project entitled "Symbionts and Malaria vectors: perspectives in a paratransgenic control", competition held in Reims (France).
Paolo Rossi, CMO: awarded a first-class honours Master’s Degree in Biomelocular and Functional Sciences at the University of Camerino in 2007.
PhD in Environmental Sciences and Public Health in Camerino in 2008. In 2009, he worked at Westminster University in London. For over 10 years he has been responsible for the insectary of the University of Camerino.
Vincenzo Palermo, CSO: Dr. Vincenzo Palermo graduated in Economics and Management of Innovation in 2007 at the Bocconi University in Milan. Subsequently, in 2013, he holds a Ph.D. in "Strategic Management and Innovation" at the Georgia Institute of Technology. He was granted the D'Onofrio-Rea Award for the best international student.
During his Ph.D., he developed academic research projects on innovation and published in the most prestigious trade magazines and in the National Bureau of Economic Research (NBER).
Palermo also identified the strategic role of licensed technologies in fostering innovation and protecting the market position in the pharmaceutical industry through the use of third party data such as IMS Health Data and IMS Patent Data.
He held the role of Data Scientist and Research Fellow at the University of Toronto in Canada from 2013 to 2016.
He deepened his studies on the pharmaceutical industry by estimating the financial costs of patent litigation at about $ 450 million using advanced analytical methods and IMS Health Data. He works in New York from 2017 as Accenture Data Science Manager where he is developing machine learning algorithms to predict economic and business events.
Stefano Falcioni, FCO: graduated in Economics and Business - Business Administration and Legislation at the University of Ancona. Chartered Accountant, Auditor, Technical Court Consultant and Expert, worked as auditor of the City of Camerino until 2015. Since 2005, he works as a chartered accountant and business consultant at his own studio in Camerino. He is currently a director of the Association of Chartered Accountants and Accounting Experts of Macerata and Camerino.